Françoise Auriol

Highly restricted deletion of the SNORD116 region is implicated in Prader–Willi Syndrome

Éric Bieth, Sanaa Eddiry, Véronique Gaston et al. · European Journal of Human Genetics · 2014 · 180 citations · Full text

Life Sciences, Genetics, Molecular Genetics +7

Effectiveness and safety of the tri-iodothyronine analogue Triac in children and adults with MCT8 deficiency: an international, single-arm, open-label, phase 2 trial

Stefan Groeneweg, Robin P. Peeters, Carla Moran et al. · The Lancet Diabetes & Endocrinology · 2019 · 126 citations · Full text

Medicine, Endocrinology, Pharmacology +4

Efficacy and Safety of Eculizumab in Pediatric Patients Affected by Shiga Toxin–Related Hemolytic and Uremic Syndrome: A Randomized, Placebo-Controlled Trial

Arnaud Garnier, Karine Brochard, Thérèsa Kwon et al. · Journal of the American Society of Nephrology · 2023 · 59 citations · Full text

Medicine, Pediatrics, Pharmacotherapy +13

Risdiplam in Patients Previously Treated with Other Therapies for Spinal Muscular Atrophy: An Interim Analysis from the JEWELFISH Study

Claudia A. Chiriboga, Claudio Bruno, Tina Duong et al. · Neurology and Therapy · 2023 · 54 citations · Full text

Medicine, Neurology, Pharmacology +16

Hyperghrelinemia Is a Common Feature of Prader-Willi Syndrome and Pituitary Stalk Interruption: A Pathophysiological Hypothesis

M. Tauber, Françoise Auriol, Pierre Moulin et al. · Hormone Research in Paediatrics · 2004 · 47 citations

Medicine, Endocrinology, Pediatrics +16